COVID-19 FAQ: Is survivors’ blood plasma an effective therapy against the illness?
COVID-19 Blood Plasma Convalent Plasma Therapy

COVID-19 FAQ: Is survivors’ blood plasma an effective therapy against the illness?

Endre Szvetnik
Endre Szvetnik

Convalescent plasma (CP) therapy to treat hospitalised COVID-19 patients has received emergency use authorisation (EUA) from the FDA in the United States. This kind of therapy is a classic prevention and treatment strategy against infectious diseases that has been in use for many decades.

Try Sparrow today

  • Read the latest science updates in just three minutes
  • Get five Digests emailed to you every week—100% free
  • No angle. No agenda. Just the facts.
  • Premium subscribers get access to the complete Sparrow library